BRAF Mutations Classes I, II, and III in NSCLC Patients Included in the SLLIP Trial: The Need for a New Pre-Clinical Treatment Rationale

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Bracht JWP, Karachaliou N, Bivona T, Lanman RB, Faull I, Nagy RJ, Drozdowskyj A, Berenguer J, Fernandez-Bruno M, Molina-Vila MA, Rosell R.

Journal title: Cancers

Journal number: 11(9)

Journal publisher: Multidisciplinary Digital Publishing Institute (MDPI)

Published year: 2019

DOI identifier: 10.3390/cancers11091381

ISSN: 2072-6694